Skip to content
The Nexus
DossierENTITY

Biovac

Coverage of Biovac in the Nexus archive.

Earliest in view: Jul 2 · 13:25 UTCMost recent: Jul 29 · 12:41 UTC
Co-mentioned in this coverage
Cholera Vaccinetopic1Africaplace1self-reliancetopic1Gaviorganization1Africa Centres for Disease Control and Preventionorganization1Shanelle Hallperson1African Unionorganization1International Finance Corporationorganization1European Investment Bankorganization1European Commissionorganization1
Recent coverage
  • HEALTHJul 29 · 12:41 UTCALLAFRICA
    Africa: Biovac's Cholera Vaccine Test for Africa's Self-Reliance

    Biovac is conducting a cholera vaccine test as part of Africa's initiative to achieve self-reliance in vaccine production. The continental effort aims to shift from vaccine dependency to local manufacturing.

  • HEALTHJul 2 · 13:25 UTCSEMAFOR
    Africa moves ahead with vaccine manufacturing ambitions

    Africa aims to produce 60% of its vaccines locally by 2040, supported by Gavi's $1.2 billion African Vaccine Manufacturing Accelerator. Initial disbursements to African manufacturers are expected in 2026, alongside efforts to secure technology transfer agreements and long-term funding for sustainable production.